INmune Bio, Inc. (INMB) Misses Q3 EPS by 8c

INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,750 at Morgan Stanley
• Barclays Reiterates Equalweight Rating on Tesla (TSLA)